In phase I clinical trials, healthy volunteers are dosed with investigational drugs and subjected to blood draws and other bodily monitoring procedures while they are confined to clinic spaces. In exchange, they are paid. These participants are, in a direct sense, selling access to their bodies for pharmaceutical companies and their associates to run drugs through. However, commodification is rarely investigated as an ethical dimension of phase I trial participation. We address this gap in the literature by bringing the voices of phase I healthy volunteers into conversation with philosophical perspectives on body commodification. Querying the intersection of commodification and phase I clinical trials illuminates important features of healthy volunteers' experiences, disentangles commodification from a dominant narrative about exploitation, and brings focus to the question of what, if any, market norms will best protect the multiple ways in which healthy volunteers' welfare is impacted by clinical trial participation.

中文翻译：

---

“我的身体是最好的商品之一”：在第一阶段健康志愿者临床试验中探索商品化的伦理。

在第一阶段的临床试验中，健康的志愿者被分配研究药物，并在他们被限制在临床空间的同时接受抽血和其他身体监测程序。作为交换，他们得到报酬。从直接的意义上讲，这些参与者是在出售他们的尸体，以供制药公司及其同事经营毒品。但是，商品化很少被作为第一阶段试验参与的伦理维度进行研究。我们通过将第一阶段健康志愿者的声音与关于身体商品化的哲学观点进行对话来解决文献中的空白。查询商品化和I期临床试验的交集，可以阐明健康志愿者经验的重要特征，将商品化与关于剥削的主流叙述区分开来，